Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout by M. N. Chikina

Subjects: Get full text

Should all people starting urate-lowering therapy for gout receive anti-inflammatory prophylaxis? by Edward Roddy, James A. Prior, Christian D. Mallen

Subjects: Get full text

Rational use of recommendations for urate-lowering therapy: clinical examples by M. S. Eliseev, O. V. Zhelyabina

Subjects: Get full text

Bridging the evidence-practice gap for people with gout by Mark D. Russell, James B. Galloway

Subjects: Get full text

Behavioral Characteristics of Gout Patients and Their Impact on the Results of Urate Lowering Therapy by J. Chen, P. Zhou, W. Tan, M. Zheng, N. Y. Oshmianska

Subjects: Get full text

Impact of urate-lowering therapy on quality of life indicators in patients with gout by M. N. Chikina, O. V. Zhelyabina, M. S. Eliseev

Subjects: Get full text

Oral Urate-Lowering Therapy Use and Efficacy Following Pegloticase Treatment: Findings from a Rheumatology Network Database by Lissa Padnick-Silver, Andrew Concoff, Hong-Ye Gao, Qianhong Fu, Brian LaMoreaux, N. Lawrence Edwards

Subjects: Get full text

UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS by M. S. Eliseev

Subjects: Get full text

Current issues in the practical use of allopurinol in patients with gout and hyperuricemia by M. S. Eliseev

Subjects: Get full text

Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1) by M. S. Eliseev

Subjects: Get full text

Is Urate-lowering therapy a prevention of first gout episode? by Michał Szczepański, Natalia Dzieszko, Maciej Borowski, Weronika Kalinowska, Paulina Sara Kulasza, Anna Ewelina Francuziak, Piotr Mikołaj Dembicki, Kinga Kozłowska, Tomasz Karol Książek, Aleksandra Szeliga

Subjects: “…urate-lowering therapy…”
Get full text

Safety and efficacy of gout treatments in people with renal impairment by Hamish Farquhar, Angelo Gaffo, Lisa K. Stamp

Subjects: Get full text

Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone by Ioana Hotea, Tanja Giesen, Antoaneta Comarniceanu, Monique Efde, Frits van Osch, Matthijs Janssen, Tim L. Jansen

Subjects: Get full text

Urate lowering therapy in primary care: rheum for improvement by Emilie Schurenberg, Edward M. Huddleston, Kenneth G. Saag

Subjects: Get full text

Colchicine for acute arthritis attacks prevention in patients with gout during urate-lowering therapy (results of a pilot study) by M. S. Eliseev, M. N. Chikina, O. V. Zhelyabina

Subjects: Get full text

Urate-lowering therapy and the risk of developing type 2 diabetes mellitus in patients with gout (results of a prospective study) by M. S. Eliseev, O. V. Zhelyabina

Subjects: Get full text

Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real? by M. S. Eliseev, Ya. I. Kuzmina

Subjects: Get full text

The ‘FebBenz’ approach for severe difficult-to-treat gout by Enrique Calvo-Aranda, Claudia María Gómez-González, Fernando Pérez-Ruiz, Marta Novella-Navarro

Subjects: Get full text

Pacific community’s perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients by Samuela Ofanoa, Malakai Ofanoa, Siobhan Tu’akoi, Hinamaha Lutui, Maryann Heather, Felicity Goodyear-Smith

Subjects: Get full text

"Focus on hyperuricemia". The resolution of the Expert Council by O. M. Drapkina, V. I. Mazurov, A. I. Martynov, I. Z. Gaidukova, D. V. Duplyakov, V. A. Nevzorova, O. D. Ostroumova, A. I. Chesnikova

Subjects: Get full text